m+Medelevator.RU
← Поиск публикаций
Revista espanola de enfermedades digestivas · 2026

Reconnecting hepatitis C patients lost to follow-up ‒ A targeted strategy.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Olveira Antonio, Domínguez-Hernández Raquel, Cano Susana, Andaluz Irene, Castillo Pilar, Romero Miriam, García-Samaniego Javier, García Araceli, Abadía Marta

Аннотация

BACKGROUND: hepatitis C virus (HCV) infection remains a major contributor to liver-related morbidity and mortality worldwide. Although direct-acting antivirals (DAAs) achieve cure rates exceeding 95 %, a substantial fraction of diagnosed patients never link to health care.

OBJECTIVES: to evaluate the effectiveness of a dual-modality retrieval strategy of mailed invitations followed by telephone outreach, to re-linking HCV-diagnosed patients lost to follow-up in the health system within a defined health area.

METHODS: from 2010 to 2018, 4,816 anti-HCV serologies were reviewed and 677 patients (449 anti-HCV positive; 228 HCV RNA positive) were identified as lost to follow-up. An administrative team sent 436 personalized letters inviting patients to contact a dedicated phone line, then made up to three calls (n = 363) to non-responders during varied days and times. Respondents were offered expedited Hepatology consultation (diagnostic confirmation, fibrosis staging) and DAA therapy.

RESULTS: of 436 patients contacted, 260 (60 %) responded (28 % via letter and 72 % via phone). Among these, 119 (47 %) enrolled in follow-up (exclusion reasons: 65 declined further care, 51 were already treated/cured elsewhere, 13 had relocated, and 12 were deceased). A total of 119 patients attended Hepatology consultation and underwent HCV RNA testing; 66 (55 %, 66/119) initiated DAAs and all achieved sustained virological response at 12 weeks post-therapy completion, representing 10 % of the original cohort and 25 % of contacts.

CONCLUSIONS: active retrieval combining mailed invitations and telephone outreach effectively re-linked lost HCV patients to health care, enabling DAA treatment and supporting national elimination goals.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты